Your browser doesn't support javascript.
loading
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Fakih, Marwan G; Kopetz, Scott; Kuboki, Yasutoshi; Kim, Tae Won; Munster, Pamela N; Krauss, John C; Falchook, Gerald S; Han, Sae-Won; Heinemann, Volker; Muro, Kei; Strickler, John H; Hong, David S; Denlinger, Crystal S; Girotto, Gustavo; Lee, Myung-Ah; Henary, Haby; Tran, Qui; Park, Joseph K; Ngarmchamnanrith, Gataree; Prenen, Hans; Price, Timothy J.
Afiliación
  • Fakih MG; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: mfakih@coh.org.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kuboki Y; National Cancer Center Hospital East, Kashiwa, Japan.
  • Kim TW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Munster PN; Department of Oncology, University of California, San Francisco, CA, USA.
  • Krauss JC; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.
  • Han SW; Seoul National University Hospital and Seoul National University Cancer Research Institute, Seoul, South Korea.
  • Heinemann V; Department of Haematology and Oncology, Comprehensive Cancer Center Munich, Ludwig-Maximilian-University of Munich, Munich, Germany.
  • Muro K; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Strickler JH; Duke University Medical Center, Durham, NC, USA.
  • Hong DS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Denlinger CS; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Girotto G; Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil.
  • Lee MA; The Catholic University of Korea Seoul St Mary's Hospital, Seoul, South Korea.
  • Henary H; Amgen, Thousand Oaks, CA, USA.
  • Tran Q; Amgen, Thousand Oaks, CA, USA.
  • Park JK; Amgen, Thousand Oaks, CA, USA.
  • Ngarmchamnanrith G; Amgen, Thousand Oaks, CA, USA.
  • Prenen H; University Hospital Antwerp, Antwerp, Belgium.
  • Price TJ; Queen Elizabeth Hospital and University of Adelaide, Woodville South, SA, Australia.
Lancet Oncol ; 23(1): 115-124, 2022 01.
Article en En | MEDLINE | ID: mdl-34919824
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Pirimidinas / Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Pirimidinas / Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) / Mutación Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article